Abstract
Aging affects energy homeostasis and fuel metabolism in a form of either an increased body mass and glucose intolerance that may lead to obesity and type 2 diabetes or loss of appetite that also may seriously compromise health status. The data, obtained mainly in rat, suggest that aging suppresses the expression and action of potent orexigenic peptides such as predominantly neuropeptides NPY and orexins and peripheral hormone, ghrelin. Senescent animals show over-responsiveness to αMSH, the major anorexigenic neuropeptide. However, central anorexigenic action of leptin is clearly diminished in aging, most likely due to the impaired leptin signal transduction. The age-related central resistance to leptin and insulin does not reduce their inhibitory effects on the activity of NPY and AgRP neurons. Thus, in rodents aging is associated with the altered expression and activity of both orexigenic and anorexigenic peptides. If similar changes in the central regulation of food intake occur during human aging, they may partially explain ‘anorexia of aging’ and loss of body weight observed at the end-of-life period. Additionally, increased plasma cholecystokinin concentrations in healthy old subjects may also contribute to the loss of appetite characteristic for the elderly. Further studies of the central and peripheral mechanisms that control food intake during aging may provide novel therapeutic strategies to improve the nutritional status of the elderly.
Keywords: Aging, food intake, hypothalamus, neuropetides, leptin, ghrelin, insulin, enteric peptides
Current Protein & Peptide Science
Title: Aging and Peptide Control of Food Intake
Volume: 12 Issue: 4
Author(s): Zbigniew Kmiec
Affiliation:
Keywords: Aging, food intake, hypothalamus, neuropetides, leptin, ghrelin, insulin, enteric peptides
Abstract: Aging affects energy homeostasis and fuel metabolism in a form of either an increased body mass and glucose intolerance that may lead to obesity and type 2 diabetes or loss of appetite that also may seriously compromise health status. The data, obtained mainly in rat, suggest that aging suppresses the expression and action of potent orexigenic peptides such as predominantly neuropeptides NPY and orexins and peripheral hormone, ghrelin. Senescent animals show over-responsiveness to αMSH, the major anorexigenic neuropeptide. However, central anorexigenic action of leptin is clearly diminished in aging, most likely due to the impaired leptin signal transduction. The age-related central resistance to leptin and insulin does not reduce their inhibitory effects on the activity of NPY and AgRP neurons. Thus, in rodents aging is associated with the altered expression and activity of both orexigenic and anorexigenic peptides. If similar changes in the central regulation of food intake occur during human aging, they may partially explain ‘anorexia of aging’ and loss of body weight observed at the end-of-life period. Additionally, increased plasma cholecystokinin concentrations in healthy old subjects may also contribute to the loss of appetite characteristic for the elderly. Further studies of the central and peripheral mechanisms that control food intake during aging may provide novel therapeutic strategies to improve the nutritional status of the elderly.
Export Options
About this article
Cite this article as:
Kmiec Zbigniew, Aging and Peptide Control of Food Intake, Current Protein & Peptide Science 2011; 12 (4) . https://dx.doi.org/10.2174/138920311795906718
DOI https://dx.doi.org/10.2174/138920311795906718 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis
Current Pharmaceutical Design Biosynthetic Pathways to Glycosidase Inhibitors
Current Chemical Biology Atrial Fibrillation: The Emerging Role of Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders-Drug Targets Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
Current HIV Research Current Clinical Therapies for Cartilage Repair, their Limitation and the Role of Stem Cells
Current Stem Cell Research & Therapy Effect of Nanogel Structure and Reaction Parameters on Activity of Immobilized Glucose Oxidase
Current Catalysis ATP-citrate Lyase: A Potential Target for Hypolipidemic Intervention
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: From Biology to Clinical Practice
Current Medicinal Chemistry Gender Dysphoria, Eating Disorders and Body Image: An Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Advanced Glycation and ROS: A Link between Diabetes and Heart Failure
Current Vascular Pharmacology Pro-oxidant- Antioxidant Balance (PAB) in Rheumatoid Arthritis and its Relationship to Disease Activity
Current Rheumatology Reviews Targeting Cardiac Mast Cells: Pharmacological Modulation of the Local Renin-Angiotensin System
Current Pharmaceutical Design Cancer-Specific Ligands Identified from Screening of Peptide-Display Libraries
Current Pharmaceutical Design Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review
Current Diabetes Reviews HDL-C Levels and Cardiovascular Disease: More is not Always Better!
Recent Patents on Cardiovascular Drug Discovery Vitamins Mediate Immunological Homeostasis and Diseases at the Surface of the Body
Endocrine, Metabolic & Immune Disorders - Drug Targets Bio-Inspired Strategies against Diabetes and Associated Complications: A Review
Recent Patents on Drug Delivery & Formulation The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives
Current Drug Metabolism The Role of Berberine in the Multi-Target Treatment of Senile Dementia
Current Topics in Medicinal Chemistry Adrenomedullin-RAMP2 System in Cardiovascular Development and Homeostasis
Current Hypertension Reviews